• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Resources

Scientific articles

Home > Resources

Scientific articles

filters

Type & Disease
Topic
Location
Date Range
Type & Disease

By Type

news type

By Disease

diseases

Topic

By Topic

topic type

Location

By Location

location-news

Date Range

By Year

date range filter – slider
1999 — 2026

Results

No results found. Please try using different filter option(s).

Statements
15 May 2026

DNDi statement on hantavirus outbreak: ‘Investment in pandemic preparedness efforts remains insufficient.’

Statements
19 May 2026

DNDi’s briefing note for 79th World Health Assembly

Close up of legs with sandals on a dry soil
Press releases
12 May 2026

DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai

Thai Rath logo
In the media
29 Apr 2026

Thailand approves ravidasvir, a new drug for hepatitis C, increasing chances of complete cure

Thai Rath
Nature Africa logo
In the media
6 May 2026

Fourteen days to recovery from kala-azar

Nature Africa
Scientific articles
30 Apr 2026

Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination

npj Antimicrobials and Resistance
Thai Rath logo
In the media
29 Apr 2026

ไทยรับรอง “ราวิดาสเวียร์” ยาใหม่รักษาไวรัสตับอักเสบซี เพิ่มโอกาสรักษาหายขาด

Thai Rath
Press releases
27 Apr 2026

Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients

Alma Preta logo
In the media
25 Apr 2026

‘Estamos na fase de eliminação’: RD Congo avança no combate à doença que matou milhões na África

Alma Preta
Times of India logo
In the media
24 Apr 2026

Dengue treatments in 2-3 years, but cases set to rise with climate change

Times of India
The New Indian Express logo
In the media
23 Apr 2026

India eyes dengue treatment rollout within five years as vaccine pipeline advances

The New Indian Express
El Mundo logo
In the media
26 Mar 2026

Un golpe de efecto para acabar con la enfermedad del sueño: “Aspiramos a eliminar el trastorno en 2030”

El Mundo
RNE logo
In the media
2 Apr 2026

La milagrosa cura de la enfermedad del sueño

RTVE
Stories

Lab lessons that matter: Pharmacy students help bridge the gap in research for neglected diseases

Stories
16 Apr 2026

One dose, one cure

Scientific articles
14 Apr 2026

Translational Pharmacokinetic-Pharmacodynamic Modeling and Efficacious Human Dose Prediction of DNDI-6148 for the Treatment of Cutaneous Leishmaniasis

Clinical and Translational Science
loading
Loading...
Scientific articles
30 Apr 2026

Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination

npj Antimicrobials and Resistance
Scientific articles
14 Apr 2026

Translational Pharmacokinetic-Pharmacodynamic Modeling and Efficacious Human Dose Prediction of DNDI-6148 for the Treatment of Cutaneous Leishmaniasis

Clinical and Translational Science
Scientific articles
27 Mar 2026

Prognostic models predicting clinical outcomes in patients diagnosed with visceral leishmaniasis: a systematic review

BMJ Public Health
Scientific articles
24 Mar 2026

The burden of eumycetoma in Africa: a neglected fungal disease

The Lancet Regional Health – Africa
Scientific articles
27 Feb 2026

Evaluation of drug–drug interaction potential between the oral antibiotic zoliflodacin and the CYP3A4 inhibitor itraconazole: A phase 1 study in healthy participants

Clinical and Translational Science
Scientific articles
27 Feb 2026

Design and analysis of randomized clinical trials for onchocerciasis, loiasis and mansonellosis: A systematic review

PLOS Neglected Tropical Diseases
Scientific articles
26 Feb 2026

A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data

Journal of Chemical Information and Modeling
Scientific articles
24 Feb 2026

Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections and associated risk factors among pregnant women and key populations in Kenya: A multi-centre cross-sectional study

PLOS Global Public Health
Scientific articles
24 Feb 2026

Elimination of visceral leishmaniasis as a public health problem in Bangladesh: Lessons learned and questions remaining

PLOS Neglected Tropical Diseases
Scientific articles
18 Feb 2026

An MRC-5 cell based high-throughput, high-content imaging assay to identify hits against Trypanosoma cruzi intracellular parasites

SLAS Discovery
Scientific articles
18 Feb 2026

Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: A phase 1, randomized, placebo-controlled trial in healthy African volunteers

Antimicrobial Agents Chemotherapy
Scientific articles
9 Feb 2026

Repurposing oxfendazole for onchocerciasis: Population pharmacokinetics of a tablet formulation in healthy African adults

CPT: Pharmacometrics & Systems Pharmacology
Scientific articles
3 Feb 2026

Evaluation of quality of care in Chagas disease cardiomyopathy

Global Heart
Scientific articles
22 Jan 2026

Analysis of the consultations on the InfoChagas digital platform

PLOS Neglected Tropical Diseases
Scientific articles
14 Jan 2026

Determinants of long-term SARS-CoV-2 immune responses in asymptomatic-to-moderate COVID-19 patients in sub-Saharan Africa

BMC Medicine
Scientific articles
14 Jan 2026

(Un)intended consequences: a social sciences stocktake of a decade of Global Action Plan-inspired antimicrobial governance

The Lancet Microbe
1 2 … 42 ›

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Youtube X-twitter Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license